Suitable for studies involving GHRH-receptor pathway characterization and method development in model systems
Aqua (Water), Centella Asiatica Leaf Water, Glycerin,Cetyl Ethylhexanoate, Cetearyl Alcohol, Glyceryl Stearate, PEG-100 Stearate, Sorbitan Stearate, Cyclopentasiloxane, 1,2-Hexanediol, Saccharide Hydrolysate, Dimethicone, Cyclohexasiloxane, Stearic Acid, Chlorphenesin, Carbomer, Glyceryl Stearate SE, Caprylyl Gl-ycol, Niacinamide, Glutathione, Xanthan Gum, Potassium Hydrox-ide, Disodium EDTA, Butylene Glycol, Dipropylene Glycol, Squalane, Asiaticoside, Madecassic Acid, Asiatic Acid, Sodium Hyaluronate, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Hippophae Rham-noides Fruit Extract, Hydrolyzed Collagen, Beta-Glucan, Nelumb-ium Speciosum Flower Extract, Artemisia Annua Extract, Oryza Sativa tiva (Rice) Extract, Saccharomyces Ferment, Ferment, Solanum Melon-Speciosum Flower Extra gena (Eggplant) Fruit Extract Rated 0 out of 5 0 reviews There are no reviews yet
Oral AOD 9604 formulations exist but have significantly lower bioavailability than subcutaneous injection
They stop dividing and can no longer grow
Both are manageable with a single syringe
Growth hormone secretagogue therapy requires evaluation by a licensed healthcare provider
